What the rollout of Covid-19 shots for ages 5 to 11 might look like
CNN
As soon as the FDA authorizes the Pfizer/BioNTech coronavirus vaccine for children ages 5 to 11 in the United States, pediatricians' offices, local pharmacies and even some schools will be ready to help get those first doses into young arms.
Vaccine makers Pfizer and BioNTech announced last week that they have submitted Covid-19 vaccine data on children ages 5 to 11 to the FDA for initial review. A formal submission to request authorization of the vaccine for young children is expected to follow in the coming weeks, the companies said. The FDA's Vaccines and Related Biological Products Advisory Committee is scheduled to meet later this month to discuss the Pfizer data.
More Related News
5 things to know for June 10: European elections, Apple, Hostage rescue, Immigration, Trash balloons
CNN’s 5 Things brings you the news you need to know every morning.